Dr. Thinzar Min Lwin, MD

Dr. Lwin practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Lwin's NPI, 1356684997, was assigned on April 2, 2013. Dr. Lwin graduated from New York Medical College in 2013. Dr. Lwin holds California license A144570.

Dr. Lwin's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Lwin's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Lwin to 1 more home health agency and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lwin practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Lwin's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Lwin is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Lwin's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists colon removal among the conditions Dr. Lwin treats.

CMS data shows 63 Medicare services from Dr. Lwin across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $8,813 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Dr. Lwin in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lwin's median patient age at 66, with 60% women.

In 2024, Dr. Lwin wrote 30 Medicare Part D claims for 20 patients. 90% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $58 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Lwin for performance year 2024, reported as part of a group. Dr. Lwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lwin as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 56 papers to Dr. Lwin, published from 2016 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Fluorescent Dyes, Mice, Nude and Optical Imaging. Dr. Lwin has published most often in Ann Surg Oncol. Dr. Lwin's most frequent co-authors are Michael Bouvet, MD, Kristin Elizabeth Cox, MD and Surinder K. Batra, MD.

Dr. Lwin graduated from New York Medical College in 2013.

Dr. Lwin is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.